LONDON and SALT LAKE CITY, March 30, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today
RNS Number : 7000U Renalytix PLC 30 March 2023 Renalytix plc ("Renalytix" or the "Company") Half Year Report LONDON and SALT LAKE CITY , March 30, 2023 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), reports its financial results for the six months ended December 31, 2022.
RNS Number : 3435U Renalytix PLC 27 March 2023 The following amendment has been made to the 'Business Update' announcement released today, 27 March 2023 at 0700 under RNS No 2296U. The real-world evidence data published in the Journal of Primary Care Community Health was published in
RNS Number : 2296U Renalytix PLC 27 March 2023 Renalytix plc ("Renalytix" or the "Company") Business Update LONDON and SALT LAKE CITY , March 27, 2023 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) provides the following business update. Renalytix has further expanded its insurance coverage
LONDON and SALT LAKE CITY, March 22, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced that it will report its second quarter and first half fiscal year 2023 financial results on Thursday, March 30, 2023, before market open.
RNS Number : 7566T Renalytix PLC 22 March 2023 Renalytix plc ("Renalytix" or the "Company") Renalytix to Report Second Quarter and First Half Fiscal Year 2023 Financial Results on March 30 LONDON and SALT LAKE CITY , March 22, 2023 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today
RNS Number : 7502T Renalytix PLC 21 March 2023 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this
RNS Number : 7492T Renalytix PLC 21 March 2023 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered
RNS Number : 5994T Renalytix PLC 21 March 2023 Renalytix plc ("Renalytix" or the "Company") Update on FDA De Novo Marketing Authorization Process LONDON and SALT LAKE CITY , March 21, 2023 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the review process with the Food and
RNS Number : 6575S Renalytix PLC 13 March 2023 Renalytix plc ("Renalytix" or the "Company") Statement re. Silicon Valley Bank LONDON and SALT LAKE CITY , March 13, 2023 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) is aware of media reports indicating the closure of Silicon Valley Bank
